Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
Clinical trial NCT00042510 · COMPLETED
Trial details
- NCT number
- NCT00042510
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2003-02-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.